America is changing fast! Sign up for our weekly newsletter to stay informed and engaged.
Read
U.S. health officials on Friday approved a closely watched Alzheimer’s drug that modestly slows the brain-robbing disease, albeit with potential safety risks that patients and their doctors will have to carefully weigh.